Moneycontrol PRO
Live: Live: Ramesh Damani on Jhunjhunwala's D-St journey
you are here: HomeNewsBusiness

Hold Alembic Pharma: target of Rs 885: ICICI Direct

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 885 in its research report dated July 27, 2021.

July 29, 2021 / 01:45 PM IST
  • bselive
  • nselive
Todays L/H

ICICI Direct's research report on Alembic Pharma

Alembic Pharma operates in international generics (54%), domestic branded (28%) and API (18%).Exports contribute 69% of sales (US~74%), domestic contributes 31% of sales (Chronic~69% & Acute~31%) It has filed 212 ANDA and has 146 approvals with 94 product launches


We maintain our HOLD rating on the stock  We value Alembic at Rs 885 i.e. 20x P/E on FY23E EPS

For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Jul 29, 2021 01:45 pm
ISO 27001 - BSI Assurance Mark